Initial PNS/PNFS Medical Necessity
For Commercial and Medicaid members, PNS or PNFS using an FDA-approved peripheral nerve stimulator may be considered medically necessary when ALL of the following criteria are met. For Medicare members, HNE has adopted InterQual criteria for Electrical Nerve Stimulators, Peripheral Nerve Stimulator NCD, and Implanted Peripheral Nerve Stimulator; see NCD 160.7, Electrical Nerve Stimulators.
ALL of the following
Chronic intractable pain for a minimum of 3 months that is refractory to at least two less-invasive treatment modalities, as appropriate to alleviate or cure the underlying condition causing the pain. Examples include, but are not limited to, physical therapy, braces, local injections, analgesics such as gabapentin or pregabalin, and acupuncture; or postsurgical and posttraumatic acute pain when FDA approved.
Appropriate documented patient education, including discussion and disclosure of treatment risks and benefits.
No active substance-abuse issues.
Formal psychological screening by a mental-health professional, with documentation of no psychological contraindications to using this treatment.
Objective evidence of pathology, such as findings on a nerve-conduction study or electromyogram.
No surgical contraindications, including infection or unacceptable medical risk.
Permanent Implantable Stimulator
A permanent implantable stimulator may be considered medically necessary only after the applicable initial requirements are met.
ALL of the following
A successful stimulation trial produced a reduction in pain intensity of at least 50%.≥ 50% reduction in pain intensity
A trial is not required for a temporary stimulator, such as Sprint.
ONE of the following pathways
Commercial/Medicaid pathway
The applicable initial PNS/PNFS criteria are met, including criteria 2 through 6: documented education and risk/benefit discussion; no active substance-abuse issues; formal psychological screening without psychological contraindications; objective evidence of pathology; and no surgical contraindications.
The applicable Medicare InterQual criteria are met for Electrical Nerve Stimulators, Peripheral Nerve Stimulator NCD, and Implanted Peripheral Nerve Stimulator.
PENFS Medical Necessity
The PENFS system (IB-STIM®) may be considered medically necessary in children and adolescents when ALL of the following criteria are met.
ALL of the following
The patient is 11 through 21 years of age.11–21 years
The patient has a ROME IV-defined functional gastrointestinal disorder, including functional abdominal pain, functional abdominal pain syndrome, irritable bowel syndrome, functional dyspepsia, or abdominal migraine.
Organic gastrointestinal disease has been ruled out, including inflammatory bowel disease, gastroesophageal reflux disease, peptic ulcer disease, celiac disease, gallstones, and gastrointestinal cancers.
The problem has been present for at least 9 months.≥ 9 months
Not Covered, Investigational, or Contraindicated Services
The following services, indications, and circumstances are not covered, investigational, experimental, or contraindicated as specified below.
Any of the following applies
PNS or PNFS is used to treat post-herpetic neuralgia, fibromyalgia, phantom limb pain, diffuse polyneuropathy, or angina pectoris; or is used for a non-FDA-approved indication. These uses are considered investigational.
PNS or PNFS criteria are not met. The service is considered not medically necessary.
Percutaneous electrical stimulation of a peripheral nerve using needles or needle electrodes is requested. This service is not covered.
An additional second or subsequent lead of a peripheral nerve stimulator is requested. This is considered experimental and investigational.
The requested PNS/PNFS service has a contraindication: BMI greater than 40, prior lumbar surgery, an implanted electronic device, or pregnancy.
PNS or PNFS for post-herpetic neuralgia, fibromyalgia, phantom limb pain, diffuse polyneuropathy, or angina pectoris, and PNS or PNFS for non-FDA-approved indications, are considered investigational.
Percutaneous electrical stimulation of a peripheral nerve using needles or needle electrodes is not covered.
The use of a second or subsequent lead of a peripheral nerve stimulator is considered experimental and investigational.
The PENFS system for indications other than the qualifying ROME IV-defined pediatric or adolescent functional gastrointestinal disorder criteria is considered experimental and investigational.
Medical-necessity determinations do not constitute a representation or warranty that a service or supply is covered or will be paid by Health New England. Benefits programs may exclude services or supplies considered medically necessary. If this guideline conflicts with the member’s benefits program, the benefits program governs. Coverage may also be mandated by applicable state or federal law or by CMS for Medicare and Medicaid members.
PNS or PNFS that does not meet the applicable medical-necessity criteria is considered not medically necessary.